Investor Shayle Kann is asking big questions about how to decarbonize the planet: How cheap can clean energy get? Will artificial intelligence speed up climate solutions? Where is the smart money going into climate technologies? Every week on Catalyst, Shayle explains the world of climate tech with prominent experts, investors, researchers, and executives. Produced by Latitude Media.
…
continue reading
Content provided by Innovation Bay. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Innovation Bay or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
E140 - Dr Julio Ribeiro, Inventia Life Science
MP3•Episode home
Manage episode 332463240 series 1836325
Content provided by Innovation Bay. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Innovation Bay or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Dr Julio Ribeiro is the Co-Founder and CEO of Inventia Life Science, a deeptech, biotechnology company. Inventia build instruments for the 3D printing of biomaterials (literal living human cells) to print 3D structures or models of tumors with an ultimate aim to accelerate the drug discovery process and speed up medical research.
The impact Julio and Inventia are looking to have is life-changing. To date, the pharmaceuticals industry has spent billions of dollars in research. According to Julio, 90% of drug trials fail. Inventia’s technology reduces the pipeline of unsuccessful drugs, speeding up the process of getting those that do work onto the market.
Inventia have to date raised $35million with the likes of Blackbird, Skipp Capital, Main Sequence and angels as investors. The top 10 pharmaceutical companies globally already utilise the technology, with labs all across the world and a global waitlist eager to use the technology. The current funds and next few years will see Inventia exploring the market and scaling up, increasing their production facilities, and expanding their sales force in US and Europe and team globally.
Quickfire Round
Book: Carl Yeung - Memories, Dreams and Reflections
Podcast: The Economist
News Source: YouTube, French 24 Channel
Tech CEO: Jamsetji Tata
Productivity Tool: Confluence, Jira
App: WhatsApp, YouTube
TV Show: Life is a movie - doesn’t watch TV or movies
Ted Talk Topic: What we can do to improve medical research with the right balance between regulations and safety.
Inventia Life Science are on the lookout for talent in the fields of biology, software engineering and always welcome interns. Head to https://inventia.life/ for more information.
See omnystudio.com/listener for privacy information.
223 episodes
MP3•Episode home
Manage episode 332463240 series 1836325
Content provided by Innovation Bay. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Innovation Bay or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Dr Julio Ribeiro is the Co-Founder and CEO of Inventia Life Science, a deeptech, biotechnology company. Inventia build instruments for the 3D printing of biomaterials (literal living human cells) to print 3D structures or models of tumors with an ultimate aim to accelerate the drug discovery process and speed up medical research.
The impact Julio and Inventia are looking to have is life-changing. To date, the pharmaceuticals industry has spent billions of dollars in research. According to Julio, 90% of drug trials fail. Inventia’s technology reduces the pipeline of unsuccessful drugs, speeding up the process of getting those that do work onto the market.
Inventia have to date raised $35million with the likes of Blackbird, Skipp Capital, Main Sequence and angels as investors. The top 10 pharmaceutical companies globally already utilise the technology, with labs all across the world and a global waitlist eager to use the technology. The current funds and next few years will see Inventia exploring the market and scaling up, increasing their production facilities, and expanding their sales force in US and Europe and team globally.
Quickfire Round
Book: Carl Yeung - Memories, Dreams and Reflections
Podcast: The Economist
News Source: YouTube, French 24 Channel
Tech CEO: Jamsetji Tata
Productivity Tool: Confluence, Jira
App: WhatsApp, YouTube
TV Show: Life is a movie - doesn’t watch TV or movies
Ted Talk Topic: What we can do to improve medical research with the right balance between regulations and safety.
Inventia Life Science are on the lookout for talent in the fields of biology, software engineering and always welcome interns. Head to https://inventia.life/ for more information.
See omnystudio.com/listener for privacy information.
223 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.